|
Extramural Support
|
RMS2014 [E]
|
$298,831,922
|
N/A
|
National Institutes of Health
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144 - 07130
|
$1,240,718
|
Alter, Blanche
|
DCEG (NCI)
|
|
Linxian nutrition intervention trials - etiologic studies
|
ZIA CP000112 - 10339
|
$90,388
|
Abnet, Christian
|
DCEG (NCI)
|
|
Aerobic Exercise for Smokers with Depressive Symptomatology
|
5R01CA173551-02
|
$539,922
|
ABRANTES, ANA
|
BUTLER HOSPITAL (PROVIDENCE, RI)
|
|
Defining mechanisms of cancer chemoresistance and metastasis
|
4R00CA172697-02
|
$241,530
|
ACHARYYA, SWARNALI
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
1U10CA180791-01
|
$737,200
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119 - 02020
|
$529,634
|
Alavanja, Michael
|
DCEG (NCI)
|
|
ATBC Study
|
ZIA CP010195 - 03031
|
$1,066,167
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Immuno/Immuno-Gene Therapies for Thoracic Malignancies
|
5P01CA066726-17
|
$1,147,325
|
ALBELDA, STEVEN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Use of Genetically Engineered T cells Targeting Tumor Stroma to Treat Lung Cancer
|
5R01CA172921-02
|
$346,942
|
ALBELDA, STEVEN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
2P30CA138313-06
|
$1,495,000
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Sit
|
1U10CA180790-01
|
$1,439,850
|
ALBERTS, STEVEN
|
MAYO CLINIC ROCHESTER
|
|
Southeast Michigan Community Network Program
|
3U54CA153606-05S1
|
$100,000
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
Southeast Michigan Community Network Program
|
5U54CA153606-05
|
$743,260
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
Unraveling Genetic Determinants of Lung Cancer Risk in African Americans
|
5K07CA172294-02
|
$160,123
|
ALDRICH, MELINDA
|
VANDERBILT UNIVERSITY
|
|
Consolidated Basic Cancer Research Program
|
2P30CA010815-45
|
$2,516,380
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-45S1
|
$92,630
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Lung cancer heterogeneity and its impact on drug resistance.
|
7R01CA133253-05
|
$232,575
|
ALTSCHULER, STEVEN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
NCTN Deep South Research Consortium
|
1U10CA180855-01
|
$497,800
|
ALVAREZ, RONALD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Targeting EphA2 in Tyrosine Kinase Inhibitor Resistant Lung Cancer
|
5F31CA167878-03
|
$27,293
|
AMATO, KATHERINE
|
VANDERBILT UNIVERSITY
|
|
Convergence of CREB and MYC Pathways in Oncogenesis.
|
4R00CA157954-03
|
$241,531
|
AMELIO, ANTONIO
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Targeted Platinates/siRNA Combination Therapy for Resistant Lung Cancer
|
1R21CA179652-01A1
|
$169,106
|
AMIJI, MANSOOR
|
NORTHEASTERN UNIVERSITY
|
|
COMBINATORIAL-DESIGNED NANO-PLATFORMS TO OVERCOME TUMOR DRUG RESISTANCE
|
5U01CA151452-05
|
$400,638
|
AMIJI, MANSOOR
|
NORTHEASTERN UNIVERSITY
|
|
Targeting both intrinsic and extrinsic apoptosis by FLLL-12 in lung cancer
|
5R03CA171663-02
|
$75,660
|
AMIN, A.R.M.
|
EMORY UNIVERSITY
|
|
Transdisciplinary Research in Cancer of the Lung (TRICL)
|
3U19CA148127-04S1
|
$453,590
|
AMOS, CHRISTOPHER
|
DARTMOUTH COLLEGE
|
|
The University of Kentucky Cancer Nanotechnology Training Center (UK CNTC)
|
5R25CA153954-05
|
$313,570
|
ANDERSON, BRADLEY
|
UNIVERSITY OF KENTUCKY
|
|
Women's Health Initiative Cancer Survivor Cohort
|
5UM1CA173642-02
|
$2,232,714
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Translating Research into Systemic Interventions for Tobacco Cessation
|
5K07CA140236-04
|
$169,560
|
APOLLONIO, DOROTHY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
1U10CA180828-01
|
$656,150
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S5
|
$10,116,159
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S6
|
$75,000
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S7
|
$122,667
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Defining a Molecularly Distinct Subtype of Non Small Cell Lung Cancer
|
5F30CA168264-02
|
$29,726
|
AUGUSTYN, ALEXANDER
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Linking State Registry and All Payer Claims Data to Study Cancer Care
|
5R21CA172892-02
|
$61,944
|
AYANIAN, JOHN
|
UNIVERSITY OF MICHIGAN
|
|
Using FAP to Selectively Target Epithelial Cancers
|
5R01CA163930-03
|
$325,084
|
BACHOVCHIN, WILLIAM
|
TUFTS UNIVERSITY BOSTON
|
|
Optical Nanoscale Analysis of Buccal Cells: Transforming Lung Cancer Screening
|
5R01CA155284-04
|
$527,979
|
BACKMAN, VADIM
|
NORTHWESTERN UNIVERSITY
|
|
A Psychosocial Intervention for the Caregivers of Advanced Lung Cancer Patients
|
1R01CA187143-01
|
$522,597
|
BADR, HODA
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
San Juan Minority-Based Community Clinical Oncology Program
|
3U10CA052667-23S1
|
$98,520
|
BAEZ, LUIS
|
SAN JUAN HEALTH DEPARTMENT
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-40S1
|
$74,856
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-40S2
|
$122,401
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-40S3
|
$150,000
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-40
|
$4,421,130
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Ras-Induced Lung Cancer: Key Roles for IKK and NF-kappaB
|
5R01CA073756-15
|
$244,798
|
BALDWIN, ALBERT
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
The role of the Kras4A isoform in epithelial carcinogenesis
|
5R01CA111834-08
|
$247,562
|
BALMAIN, ALLAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Synthetic-Lethal-Based Targeted Therapy for Oncogenic KRAS-Driven Cancer
|
5K08CA138918-05
|
$178,200
|
BARBIE, DAVID
|
DANA-FARBER CANCER INST
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
1U10CA180833-01
|
$1,548,433
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Reducing Cancer Disparaties Among Latinos in Texas
|
3U54CA153505-05S1
|
$65,835
|
BASEN-ENGQUIST, KAREN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Reducing Cancer Disparaties Among Latinos in Texas
|
5U54CA153505-05
|
$751,613
|
BASEN-ENGQUIST, KAREN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Clinical Studies to Circumvent Drug Resistance
|
ZIA BC 010620
|
$93,272
|
Bates, Susan
|
CCR (NCI)
|
|
Translational Studies of the Histone Deacetylase Inhibitor Romidepsin
|
ZIA BC 010621
|
$699,543
|
Bates, Susan
|
CCR (NCI)
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|